Page last updated: 2024-10-31

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and Astrocytoma, Grade IV

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide has been researched along with Astrocytoma, Grade IV in 1 studies

N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide: calmodulin antagonist; structure given in first source
N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide : A sulfonamide that is 5-chloronaphthalene-2-sulfonamide in which one of the hydrogens of the nitrogen atom is substituted by a 4-aminobutyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xiong, DD1
Xu, WQ1
He, RQ1
Dang, YW1
Chen, G1
Luo, DZ1

Other Studies

1 other study available for n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and Astrocytoma, Grade IV

ArticleYear
In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
    Oncology reports, 2019, Volume: 41, Issue:4

    Topics: Androstadienes; Antineoplastic Agents; Brain Neoplasms; Computational Biology; Drug Discovery; Gefit

2019